U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are ...

A report released Thursday said highly processed foods, exposure to chemicals and excessive use of prescription drugs are ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

They're brightly colored, packed in enticing boxes and often marketed as healthy -- but many cereals today are actually less ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

Government advisers are convening to discuss potential COVID-19 vaccine updates for the fall and winter, amidst a new policy that limits routine boosters to seniors and high-risk individuals. The FDA ...

The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.